Cargando…
Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
BACKGROUND: Paclitaxel (PTX) is a potent anti-cancer drug commonly used for the treatment of advanced breast cancer (BCA) and melanoma. Toll-like receptor 4 (TLR4) promotes the production of pro-inflammatory cytokines associated with cancer chemoresistance. This study aims to explore the effect of T...
Autores principales: | Sootichote, Rochanawan, Thuwajit, Peti, Singsuksawat, Ekapot, Warnnissorn, Malee, Yenchitsomanus, Pa-thai, Ithimakin, Suthinee, Chantharasamee, Jomjit, Thuwajit, Chanitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830047/ https://www.ncbi.nlm.nih.gov/pubmed/29486738 http://dx.doi.org/10.1186/s12885-018-4155-6 |
Ejemplares similares
-
Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells
por: Singsuksawat, Ekapot, et al.
Publicado: (2018) -
Mesothelin-specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3-treated self-differentiated dendritic cells
por: Jirapongwattana, Niphat, et al.
Publicado: (2022) -
Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells
por: Sumransub, Nuttavut, et al.
Publicado: (2020) -
Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
por: Thongchot, Suyanee, et al.
Publicado: (2020) -
Nucleolin-based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)
por: Thongchot, Suyanee, et al.
Publicado: (2023)